...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Liquidity

fouremm - DM has alluded to in the past that going public would happen when there was an event worthy of it.

Share
New Message
Please login to post a reply